Watermark
  Back to Search Results

BGB-LC-202

Completed

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-LC-202

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05577702

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20222760

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents